You are here: Industry Insights > Sanofi

News List

Philippines officials nix Sanofi's attempt to bring Dengvaxia back to market fiercepharma
August 25, 2019
Sanofi has been through an ordeal with its Dengvaxia rollout in the Philippines, but earlier this month, it looked as if officials might reintroduce the dengue vaccine to battle a deadly outbreak. For now, though, that's off the table.
Sanofi defends top oncology drug with Jevtana patent win fiercepharma
August 18, 2019
Sanofi and generic drugmakers have been battling back and forth over patents protecting the company’s top oncology product, Jevtana. In the latest round, Sanofi proved victorious.
Philippine officials consider Sanofi's Dengvaxia—again—amid deadly outbreak fiercepharma
August 13, 2019
It’s hard to imagine Sanofi’s Dengvaxia rollout in the Philippines going worse than it did, what with investigations and allegations that the shot caused deaths in children. But authorities are considering introducing the vaccine again to fight an outbrea
Regeneron's Sanofi deal finally turns a profit, thanks to Dupixent fiercepharma
August 07, 2019
More than 10 years after Sanofi and Regeneron joined forces in a high-profile antibody drug partnership, the tie-up has recorded its first-ever profits—no thanks to the PCSK9 laggard Praluent, but with big bouquets for hard-driving Dupixent.
Sanofi and Regeneron get EU approval for Dupixent expresspharma
August 07, 2019
European Commission has extended marketing authorisation for Dupixent European Union to include adolescents 12 to 17 years of age with moderate-to-severe atopic dermatitis
Sanofi’s Dupixent met study endpoints in children with atopic dermatitis pharmaceutical-technology
August 07, 2019
Sanofi has announced positive top-line, Phase III results for Dupixent (dupilumab) in children aged six to 11 years old with atopic dermatitis.
Sanofi to develop Verastem’s Copiktra in certain regions pharmaceutical-technology
July 29, 2019
Sanofi has signed a licensing agreement to develop and commercialise Verastem Oncology’s Copiktra (duvelisib) in Russia and CIS, Turkey, the Middle East and Africa.
Sanofi gains OTC rights to Roche’s Tamiflu in US pharmaceutical-technology
July 24, 2019
Sanofi has entered an agreement to obtain the exclusive over-the-counter (OTC) rights for Roche’s Tamiflu medicine.
Amgen wins patent block on Sanofi drug rival drugs
July 16, 2019
Amgen has successfully blocked the manufacture, sales and marketing of its Sanofi drug rival in Germany.
Catalent Expands Global Spray Drying Ops contractpharma
July 10, 2019
Agreement with Sanofi Active Ingredient Solutions provides access to spray drying manufacturing services at Sanofi’s Haverhill, UK facility.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page